192 related articles for article (PubMed ID: 6269793)
1. [Clinical experience with a new antihypertensive drug (captopril SQ 14.225), an oral inhibitor of converting enzyme].
Santucci A; Aguglia F; Ficara C
Clin Ter; 1981 Apr; 97(1):43-58. PubMed ID: 6269793
[No Abstract] [Full Text] [Related]
2. [Potentiation of the antihypertensive effect of captopril by diuretics (author's transl)].
Waeber B; Brunner HR; Turini GA; Curtet N; Keller I; Gavras H
Ann Cardiol Angeiol (Paris); 1979; 28(1):9-11. PubMed ID: 219758
[No Abstract] [Full Text] [Related]
3. [Long term treatment of resistant hypertension with captopril (author's transl)].
Guedon J; Chaignon M; Lucsko M; Cuche JL; Aubert P; Piete AM
Nouv Presse Med; 1981 Apr; 10(19):1565-9. PubMed ID: 7025846
[TBL] [Abstract][Full Text] [Related]
4. [Treatment of severe arterial hypertension with captopril (SQ 14.225) (author's transl)].
Di Giulio S; Perez-Ramirez JL; Jamoun P; Grünfeld JP; Meyer P
Nouv Presse Med; 1981 Apr; 10(19):1551-5. PubMed ID: 6269557
[TBL] [Abstract][Full Text] [Related]
5. Antihypertensive effect of the oral angiotensin converting-enzyme inhibitor SQ 14225 in man.
Gavras H; Brunner HR; Turini GA; Kershaw GR; Tifft CP; Cuttelod S; Gavras I; Vukovich RA; McKinstry DN
N Engl J Med; 1978 May; 298(18):991-5. PubMed ID: 205788
[TBL] [Abstract][Full Text] [Related]
6. [Use of SQ 14225 in the treatment of essential arterial hypertension].
Degli Esposti E; Chiarini C; Fusaroli M; Masi A; Santoro A; Sturani A; Zuccalà A; Zucchelli P
Clin Ter; 1981 Apr; 97(2):153-63. PubMed ID: 6263540
[No Abstract] [Full Text] [Related]
7. [Effect of captopril in essential hypertension (author's transl)].
Mimran A; Targhetta R; Laroche B
Nouv Presse Med; 1981 Apr; 10(19):1579-82. PubMed ID: 7025849
[TBL] [Abstract][Full Text] [Related]
8. [Effect of inhibition of converting enzyme by captopril on arterial pressure, renin and aldosterone in essential hypertension].
Posadas C; Sánchez G; Boyer JL; Delmar M; Serrano PA
Arch Inst Cardiol Mex; 1982; 52(4):295-300. PubMed ID: 6291470
[TBL] [Abstract][Full Text] [Related]
9. [Angiotensin converting enzyme inhibitors--a new group of hypotensive drugs].
Lazowski J
Wiad Lek; 1984 May; 37(10):792-6. PubMed ID: 6095537
[No Abstract] [Full Text] [Related]
10. Efficacy of an oral angiotensin-converting enzyme inhibitor (captopril) in severe hypertension.
Zweifler AJ; Julius S; Nicholls MG
Arch Intern Med; 1981 Jun; 141(7):907-10. PubMed ID: 6263204
[TBL] [Abstract][Full Text] [Related]
11. [Captopril in the therapy of resistant hypertension. A multicenter study].
Mion Júnior D; Silva HB; Marcondes M
Arq Bras Cardiol; 1983 May; 40(5):363-7. PubMed ID: 6360101
[No Abstract] [Full Text] [Related]
12. Captopril in primary hypertension. Effects related to the renin-angiotensin-aldosterone and kallikrein-kinin systems.
Ohman KP; Karlberg BE; Nilsson OR; Wettre S
Acta Med Scand Suppl; 1981; 646():98-105. PubMed ID: 7018190
[TBL] [Abstract][Full Text] [Related]
13. A discrepancy between the effects of a single oral dose of captopril on blood pressure, plasma renin activity, and serum angiotensin-converting enzyme levels.
Lechi A; Covi G; Capuzzo MG; Lechi C; Minuz P; Delva P; Scuro LA
Int J Clin Pharmacol Ther Toxicol; 1983 Nov; 21(11):569-74. PubMed ID: 6317579
[TBL] [Abstract][Full Text] [Related]
14. Angiotensin-converting enzyme inhibitors: pathogenic and therapeutic implications for arterial hypertension.
Waeber B; Brunner HR; Wauters JP; Gavras H
Adv Nephrol Necker Hosp; 1981; 10():111-33. PubMed ID: 6267906
[No Abstract] [Full Text] [Related]
15. [Acute inhibition of angiotensin-converting enzyme by captopril. Hemodynamic and biochemical aspects in normotension and essential hypertension].
Stanek B; Templ H; Pohanka E; Silberbauer K
Acta Med Austriaca; 1982; 9(5-6):175-80. PubMed ID: 6299046
[No Abstract] [Full Text] [Related]
16. Captopril and salt subtraction to treat "uncontrollable" hypertension in haemodialysis patients.
Wauters JP; Waeber B; Brunner HR; Turini GA; Guignard JP; Gavras H
Proc Eur Dial Transplant Assoc; 1979; 16():610-7. PubMed ID: 232915
[TBL] [Abstract][Full Text] [Related]
17. [Treatment of essential arterial hypertension of moderate severity with an orally active inhibitor of the angiotensin converting enzyme (Captopril)].
Guerrera G; Melina D
Minerva Cardioangiol; 1983 Mar; 31(3):101-6. PubMed ID: 6304570
[No Abstract] [Full Text] [Related]
18. [A new point of attack for the treatment of hypertension; captopril, an orally active inhibitor of the enzymatic conversion of angiotensin I into angiotensin II].
Schalekamp MA; de Bruyn JH; Wenting GJ; Man in 't Veld AJ; Derkx FH
Ned Tijdschr Geneeskd; 1980 Nov; 124(47):1996-2003. PubMed ID: 6255350
[No Abstract] [Full Text] [Related]
19. Clinical experience with the angiotensin converting enzyme inhibitor captopril.
Walter NM; Whitworth JA; Kincaid-Smith P
Clin Exp Pharmacol Physiol Suppl; 1982; 7():117-21. PubMed ID: 6291829
[TBL] [Abstract][Full Text] [Related]
20. [Chronic treatment of hypertension by an inhibitor of angiotensin converting enzyme].
Waeber B; Gavras H; Brunner HR; Chappuis P; Turini GA
Schweiz Med Wochenschr; 1978 Dec; 108(49):1981-3. PubMed ID: 219469
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
